Literature DB >> 23346910

Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.

Zachary A Hing1, Tal Schiller, Andrew Wu, Nobuko Hamasaki-Katagiri, Evi Budo Struble, Estelle Russek-Cohen, Chava Kimchi-Sarfaty.   

Abstract

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare, recessively inherited genetic disorder with varying clinical presentation that is caused by ADAMTS13 mutations. Several studies have found limited associations between ADAMTS13 mutations and cTTP phenotype. The use of in silico tools that examine multiple mutation characteristics may better predict phenotype. We analysed 118 ADAMTS13 mutations found in 144 cTTP patients reported in the literature and examined associations of several mutation characteristics, including N-terminal proximity, the evolutionary conservation of the affected amino acid position, as well as amino acid charge/phosphorylation and genetic codon usage to disease phenotype. Structure-altering mutations were examined for their impact on ADAMTS13 function based on existing ADAMTS13 crystallographic data (AA 77-685). Our in silico data indicate that: (i) The position of the mutation in the N- or C-terminus, (ii) evolutionary conservation and (iii) codon usage of the affected mutation position are associated with disease parameters, such as age of onset, organ damage and fresh frozen plasma prophylaxis. In conclusion, the usage of multiple in silico tools presents a promising strategy in refining predictions for the diverse presentation of cTTP. Enhancing our utilization of in silico tools to find genotype-phenotype associations will create better-tailored approaches for individual patient treatment. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23346910     DOI: 10.1111/bjh.12214

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Candidate gene analysis using genomic quantitative PCR: identification of ADAMTS13 large deletions in two patients with Upshaw-Schulman syndrome.

Authors:  Yuka Eura; Koichi Kokame; Toshiro Takafuta; Ryojiro Tanaka; Hikaru Kobayashi; Fumihiro Ishida; Shuichi Hisanaga; Masanori Matsumoto; Yoshihiro Fujimura; Toshiyuki Miyata
Journal:  Mol Genet Genomic Med       Date:  2014-01-14       Impact factor: 2.183

2.  De Novo Mutation of the ADAMTS13 Gene with Mesenteric Ischemia in an Infant with Congenital Thrombotic Thrombocytopenic Purpura.

Authors:  Ibrahim Alharbi; Sarah Alqarni; Wed Khayyat; Amirah Almatrafi
Journal:  Case Rep Hematol       Date:  2021-07-06

3.  Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next-generation sequencing.

Authors:  Teresa Fidalgo; Patrícia Martinho; Catarina S Pinto; Ana C Oliveira; Ramon Salvado; Nina Borràs; Margarida Coucelo; Licínio Manco; Tabita Maia; M João Mendes; Rafael Del Orbe Barreto; Irene Corrales; Francisco Vidal; M Letícia Ribeiro
Journal:  Res Pract Thromb Haemost       Date:  2017-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.